E-LIB Suche - Ergebnisse für: Gjerum, Le

1

555 - Safety of tralokinumab for the treatment of atopic de..:

Reich, Kristian ; Langley, Richard G ; Silvestre, Juan Francisco...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii52-ii53 , 2024

Link: https://doi.org/10.1093/..

2

551 - Continuous tralokinumab treatment over 4 years in adu..:

Blauvelt, Andrew ; Langley, Richard G ; Peris, Ketty...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii48-ii49 , 2024

Link: https://doi.org/10.1093/..

3

Continuous Tralokinumab Treatment over 4 Years in Adults wi..:

Blauvelt, Andrew ; Langley, Richard G. ; Peris, Ketty...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s376 , 2024

Link: https://doi.org/10.25251..

4

Safety of Tralokinumab for the Treatment of Atopic Dermatit..:

Reich, Kristian ; Langley, Richard G. ; Silvestre, Juan Francisco...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s375 , 2024

Link: https://doi.org/10.25251..

5

Tralokinumab demonstrated a consistent safety profile with ..:

Reich, Kristian ; Simpson, Eric ; Langley, Richard...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s143 , 2023

Link: https://doi.org/10.25251..

6

309 Tralokinumab demonstrated a consistent safety profile w..:

Reich, Kristian ; Simpson, Eric ; Langley, Richard...
British Journal of Dermatology. 188 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

Tralokinumab demonstrated a consistent safety profile with ..:

Reich, Kristian ; Simpson, Eric L ; Langley, Richard...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s79 , 2022

Link: https://doi.org/10.25251..

8

Long-term 2-year safety and efficacy of tralokinumab in adu..:

Blauvelt, Andrew ; Langley, Richard G. ; Lacour, Jean-Philippe...
Journal of the American Academy of Dermatology. 87 (2022) 4 - p. 815-824 , 2022

Link: https://doi.org/10.1016/..

9

COVID-19 in tralokinumab-treated patients with moderate-to-..:

Blauvelt, Andrew ; Pink, Andrew ; Worm, Margitta...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 6 - p. s58 , 2021

Link: https://doi.org/10.25251..

10

Comparing a Single Clinician Versus a Multidisciplinary Con..:

Thorlacius-Ussing, Gorm ; Bruun, Marie ; Gjerum, Le...
Journal of Alzheimer's Disease. 83 (2021) 2 - p. 741-751 , 2021

Link: https://doi.org/10.3233/..

11

Comparison of the clinical impact of 2-[18F]FDG-PET and cer..:

Gjerum, Le ; Andersen, Birgitte Bo ; Bruun, Marie...
PLOS ONE. 16 (2021) 3 - p. e0248413 , 2021

Link: https://doi.org/10.1371/..

12

Evaluating 2-[18F]FDG-PET in differential diagnosis of deme..:

Gjerum, Le ; Frederiksen, Kristian Steen ; Henriksen, Otto Mølby...
NeuroImage: Clinical. 27 (2020) - p. 102267 , 2020

Link: https://doi.org/10.1016/..

13

Prognostic value of complementary biomarkers of neurodegene..:

Gramkow, Mathias Holsey ; Gjerum, Le ; Koikkalainen, Juha...
PeerJ. 8 (2020) - p. e9498 , 2020

Link: https://doi.org/10.7717/..

14

A visual rating scale for cingulate island sign on 18F-FDG-..:

Gjerum, Le ; Frederiksen, Kristian Steen ; Henriksen, Otto Mølby...
Journal of the Neurological Sciences. 410 (2020) - p. 116645 , 2020

Link: https://doi.org/10.1016/..

15

Impact of a clinical decision support tool on prediction of..:

Bruun, Marie ; Frederiksen, Kristian S. ; Rhodius-Meester, Hanneke F. M....
Alzheimer's Research & Therapy. 11 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..